Global Cancer Tumor Profiling Market Growth (Status and Outlook) 2023-2028

Report ID: 1339215 | Published Date: Jan 2025 | No. of Page: 114 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Cancer Tumor Profiling Market Size 2017-2028
        2.1.2 Cancer Tumor Profiling Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Cancer Tumor Profiling Segment by Type
        2.2.1 Next-generation Sequencing (NGS)
        2.2.2 Polymerase Chain Reaction (PCR)
        2.2.3 Immunohistochemistry (IHC)
        2.2.4 In Situ Hybridization (ISH)
        2.2.5 Microarray
        2.2.6 Others
    2.3 Cancer Tumor Profiling Market Size by Type
        2.3.1 Cancer Tumor Profiling Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Cancer Tumor Profiling Market Size Market Share by Type (2017-2022)
    2.4 Cancer Tumor Profiling Segment by Application
        2.4.1 Personalized Medicine
        2.4.2 Diagnostics
        2.4.3 Biomarker Discovery
        2.4.4 Prognostics
        2.4.5 Research Applications
    2.5 Cancer Tumor Profiling Market Size by Application
        2.5.1 Cancer Tumor Profiling Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Cancer Tumor Profiling Market Size Market Share by Application (2017-2022)
3 Cancer Tumor Profiling Market Size by Player
    3.1 Cancer Tumor Profiling Market Size Market Share by Players
        3.1.1 Global Cancer Tumor Profiling Revenue by Players (2020-2022)
        3.1.2 Global Cancer Tumor Profiling Revenue Market Share by Players (2020-2022)
    3.2 Global Cancer Tumor Profiling Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Cancer Tumor Profiling by Regions
    4.1 Cancer Tumor Profiling Market Size by Regions (2017-2022)
    4.2 Americas Cancer Tumor Profiling Market Size Growth (2017-2022)
    4.3 APAC Cancer Tumor Profiling Market Size Growth (2017-2022)
    4.4 Europe Cancer Tumor Profiling Market Size Growth (2017-2022)
    4.5 Middle East & Africa Cancer Tumor Profiling Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Cancer Tumor Profiling Market Size by Country (2017-2022)
    5.2 Americas Cancer Tumor Profiling Market Size by Type (2017-2022)
    5.3 Americas Cancer Tumor Profiling Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Cancer Tumor Profiling Market Size by Region (2017-2022)
    6.2 APAC Cancer Tumor Profiling Market Size by Type (2017-2022)
    6.3 APAC Cancer Tumor Profiling Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Cancer Tumor Profiling by Country (2017-2022)
    7.2 Europe Cancer Tumor Profiling Market Size by Type (2017-2022)
    7.3 Europe Cancer Tumor Profiling Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Cancer Tumor Profiling by Region (2017-2022)
    8.2 Middle East & Africa Cancer Tumor Profiling Market Size by Type (2017-2022)
    8.3 Middle East & Africa Cancer Tumor Profiling Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Cancer Tumor Profiling Market Forecast
    10.1 Global Cancer Tumor Profiling Forecast by Regions (2023-2028)
        10.1.1 Global Cancer Tumor Profiling Forecast by Regions (2023-2028)
        10.1.2 Americas Cancer Tumor Profiling Forecast
        10.1.3 APAC Cancer Tumor Profiling Forecast
        10.1.4 Europe Cancer Tumor Profiling Forecast
        10.1.5 Middle East & Africa Cancer Tumor Profiling Forecast
    10.2 Americas Cancer Tumor Profiling Forecast by Country (2023-2028)
        10.2.1 United States Cancer Tumor Profiling Market Forecast
        10.2.2 Canada Cancer Tumor Profiling Market Forecast
        10.2.3 Mexico Cancer Tumor Profiling Market Forecast
        10.2.4 Brazil Cancer Tumor Profiling Market Forecast
    10.3 APAC Cancer Tumor Profiling Forecast by Region (2023-2028)
        10.3.1 China Cancer Tumor Profiling Market Forecast
        10.3.2 Japan Cancer Tumor Profiling Market Forecast
        10.3.3 Korea Cancer Tumor Profiling Market Forecast
        10.3.4 Southeast Asia Cancer Tumor Profiling Market Forecast
        10.3.5 India Cancer Tumor Profiling Market Forecast
        10.3.6 Australia Cancer Tumor Profiling Market Forecast
    10.4 Europe Cancer Tumor Profiling Forecast by Country (2023-2028)
        10.4.1 Germany Cancer Tumor Profiling Market Forecast
        10.4.2 France Cancer Tumor Profiling Market Forecast
        10.4.3 UK Cancer Tumor Profiling Market Forecast
        10.4.4 Italy Cancer Tumor Profiling Market Forecast
        10.4.5 Russia Cancer Tumor Profiling Market Forecast
    10.5 Middle East & Africa Cancer Tumor Profiling Forecast by Region (2023-2028)
        10.5.1 Egypt Cancer Tumor Profiling Market Forecast
        10.5.2 South Africa Cancer Tumor Profiling Market Forecast
        10.5.3 Israel Cancer Tumor Profiling Market Forecast
        10.5.4 Turkey Cancer Tumor Profiling Market Forecast
        10.5.5 GCC Countries Cancer Tumor Profiling Market Forecast
    10.6 Global Cancer Tumor Profiling Forecast by Type (2023-2028)
    10.7 Global Cancer Tumor Profiling Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Qiagen N.V.
        11.1.1 Qiagen N.V. Company Information
        11.1.2 Qiagen N.V. Cancer Tumor Profiling Product Offered
        11.1.3 Qiagen N.V. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Qiagen N.V. Main Business Overview
        11.1.5 Qiagen N.V. Latest Developments
    11.2 Roche Molecular Systems Inc.
        11.2.1 Roche Molecular Systems Inc. Company Information
        11.2.2 Roche Molecular Systems Inc. Cancer Tumor Profiling Product Offered
        11.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Roche Molecular Systems Inc. Main Business Overview
        11.2.5 Roche Molecular Systems Inc. Latest Developments
    11.3 Abott Molecular
        11.3.1 Abott Molecular Company Information
        11.3.2 Abott Molecular Cancer Tumor Profiling Product Offered
        11.3.3 Abott Molecular Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 Abott Molecular Main Business Overview
        11.3.5 Abott Molecular Latest Developments
    11.4 Illumina Inc.
        11.4.1 Illumina Inc. Company Information
        11.4.2 Illumina Inc. Cancer Tumor Profiling Product Offered
        11.4.3 Illumina Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 Illumina Inc. Main Business Overview
        11.4.5 Illumina Inc. Latest Developments
    11.5 NeoGenomics Laboratories
        11.5.1 NeoGenomics Laboratories Company Information
        11.5.2 NeoGenomics Laboratories Cancer Tumor Profiling Product Offered
        11.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 NeoGenomics Laboratories Main Business Overview
        11.5.5 NeoGenomics Laboratories Latest Developments
    11.6 HTG Molecular Diagnostic
        11.6.1 HTG Molecular Diagnostic Company Information
        11.6.2 HTG Molecular Diagnostic Cancer Tumor Profiling Product Offered
        11.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 HTG Molecular Diagnostic Main Business Overview
        11.6.5 HTG Molecular Diagnostic Latest Developments
    11.7 Genomic Health Inc.
        11.7.1 Genomic Health Inc. Company Information
        11.7.2 Genomic Health Inc. Cancer Tumor Profiling Product Offered
        11.7.3 Genomic Health Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Genomic Health Inc. Main Business Overview
        11.7.5 Genomic Health Inc. Latest Developments
    11.8 Hologic Gen-Probe
        11.8.1 Hologic Gen-Probe Company Information
        11.8.2 Hologic Gen-Probe Cancer Tumor Profiling Product Offered
        11.8.3 Hologic Gen-Probe Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Hologic Gen-Probe Main Business Overview
        11.8.5 Hologic Gen-Probe Latest Developments
    11.9 BD Biosciences
        11.9.1 BD Biosciences Company Information
        11.9.2 BD Biosciences Cancer Tumor Profiling Product Offered
        11.9.3 BD Biosciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 BD Biosciences Main Business Overview
        11.9.5 BD Biosciences Latest Developments
    11.10 Siemens Healthineers
        11.10.1 Siemens Healthineers Company Information
        11.10.2 Siemens Healthineers Cancer Tumor Profiling Product Offered
        11.10.3 Siemens Healthineers Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 Siemens Healthineers Main Business Overview
        11.10.5 Siemens Healthineers Latest Developments
    11. Claris Life Sciences
        11.11.1 Claris Life Sciences Company Information
        11.11.2 Claris Life Sciences Cancer Tumor Profiling Product Offered
        11.11.3 Claris Life Sciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 Claris Life Sciences Main Business Overview
        11.11.5 Claris Life Sciences Latest Developments
    11.12 Personal Genome Diagnostics, Inc.
        11.12.1 Personal Genome Diagnostics, Inc. Company Information
        11.12.2 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product Offered
        11.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 Personal Genome Diagnostics, Inc. Main Business Overview
        11.12.5 Personal Genome Diagnostics, Inc. Latest Developments
    11.13 Perthera, Inc.
        11.13.1 Perthera, Inc. Company Information
        11.13.2 Perthera, Inc. Cancer Tumor Profiling Product Offered
        11.13.3 Perthera, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2020-2022)
        11.13.4 Perthera, Inc. Main Business Overview
        11.13.5 Perthera, Inc. Latest Developments
    11.14 Foundation Medicine, Inc
        11.14.1 Foundation Medicine, Inc Company Information
        11.14.2 Foundation Medicine, Inc Cancer Tumor Profiling Product Offered
        11.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2020-2022)
        11.14.4 Foundation Medicine, Inc Main Business Overview
        11.14.5 Foundation Medicine, Inc Latest Developments
    11.15 V., Strand
        11.15.1 V., Strand Company Information
        11.15.2 V., Strand Cancer Tumor Profiling Product Offered
        11.15.3 V., Strand Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2020-2022)
        11.15.4 V., Strand Main Business Overview
        11.15.5 V., Strand Latest Developments
    11.16 ApoCell
        11.16.1 ApoCell Company Information
        11.16.2 ApoCell Cancer Tumor Profiling Product Offered
        11.16.3 ApoCell Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2020-2022)
        11.16.4 ApoCell Main Business Overview
        11.16.5 ApoCell Latest Developments
    11.17 Contextual Genomics
        11.17.1 Contextual Genomics Company Information
        11.17.2 Contextual Genomics Cancer Tumor Profiling Product Offered
        11.17.3 Contextual Genomics Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2020-2022)
        11.17.4 Contextual Genomics Main Business Overview
        11.17.5 Contextual Genomics Latest Developments
    11.18 Agendia
        11.18.1 Agendia Company Information
        11.18.2 Agendia Cancer Tumor Profiling Product Offered
        11.18.3 Agendia Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2020-2022)
        11.18.4 Agendia Main Business Overview
        11.18.5 Agendia Latest Developments
    11.19 GenScript
        11.19.1 GenScript Company Information
        11.19.2 GenScript Cancer Tumor Profiling Product Offered
        11.19.3 GenScript Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2020-2022)
        11.19.4 GenScript Main Business Overview
        11.19.5 GenScript Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Cancer Tumor Profiling Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Next-generation Sequencing (NGS)
    Table 3. Major Players of Polymerase Chain Reaction (PCR)
    Table 4. Major Players of Immunohistochemistry (IHC)
    Table 5. Major Players of In Situ Hybridization (ISH)
    Table 6. Major Players of Microarray
    Table 7. Major Players of Others
    Table 8. Cancer Tumor Profiling Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 9. Global Cancer Tumor Profiling Market Size by Type (2017-2022) & ($ Millions)
    Table 10. Global Cancer Tumor Profiling Market Size Market Share by Type (2017-2022)
    Table 11. Cancer Tumor Profiling Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 12. Global Cancer Tumor Profiling Market Size by Application (2017-2022) & ($ Millions)
    Table 13. Global Cancer Tumor Profiling Market Size Market Share by Application (2017-2022)
    Table 14. Global Cancer Tumor Profiling Revenue by Players (2020-2022) & ($ Millions)
    Table 15. Global Cancer Tumor Profiling Revenue Market Share by Player (2020-2022)
    Table 16. Cancer Tumor Profiling Key Players Head office and Products Offered
    Table 17. Cancer Tumor Profiling Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 18. New Products and Potential Entrants
    Table 19. Mergers & Acquisitions, Expansion
    Table 20. Global Cancer Tumor Profiling Market Size by Regions 2017-2022 & ($ Millions)
    Table 21. Global Cancer Tumor Profiling Market Size Market Share by Regions (2017-2022)
    Table 22. Americas Cancer Tumor Profiling Market Size by Country (2017-2022) & ($ Millions)
    Table 23. Americas Cancer Tumor Profiling Market Size Market Share by Country (2017-2022)
    Table 24. Americas Cancer Tumor Profiling Market Size by Type (2017-2022) & ($ Millions)
    Table 25. Americas Cancer Tumor Profiling Market Size Market Share by Type (2017-2022)
    Table 26. Americas Cancer Tumor Profiling Market Size by Application (2017-2022) & ($ Millions)
    Table 27. Americas Cancer Tumor Profiling Market Size Market Share by Application (2017-2022)
    Table 28. APAC Cancer Tumor Profiling Market Size by Region (2017-2022) & ($ Millions)
    Table 29. APAC Cancer Tumor Profiling Market Size Market Share by Region (2017-2022)
    Table 30. APAC Cancer Tumor Profiling Market Size by Type (2017-2022) & ($ Millions)
    Table 31. APAC Cancer Tumor Profiling Market Size Market Share by Type (2017-2022)
    Table 32. APAC Cancer Tumor Profiling Market Size by Application (2017-2022) & ($ Millions)
    Table 33. APAC Cancer Tumor Profiling Market Size Market Share by Application (2017-2022)
    Table 34. Europe Cancer Tumor Profiling Market Size by Country (2017-2022) & ($ Millions)
    Table 35. Europe Cancer Tumor Profiling Market Size Market Share by Country (2017-2022)
    Table 36. Europe Cancer Tumor Profiling Market Size by Type (2017-2022) & ($ Millions)
    Table 37. Europe Cancer Tumor Profiling Market Size Market Share by Type (2017-2022)
    Table 38. Europe Cancer Tumor Profiling Market Size by Application (2017-2022) & ($ Millions)
    Table 39. Europe Cancer Tumor Profiling Market Size Market Share by Application (2017-2022)
    Table 40. Middle East & Africa Cancer Tumor Profiling Market Size by Region (2017-2022) & ($ Millions)
    Table 41. Middle East & Africa Cancer Tumor Profiling Market Size Market Share by Region (2017-2022)
    Table 42. Middle East & Africa Cancer Tumor Profiling Market Size by Type (2017-2022) & ($ Millions)
    Table 43. Middle East & Africa Cancer Tumor Profiling Market Size Market Share by Type (2017-2022)
    Table 44. Middle East & Africa Cancer Tumor Profiling Market Size by Application (2017-2022) & ($ Millions)
    Table 45. Middle East & Africa Cancer Tumor Profiling Market Size Market Share by Application (2017-2022)
    Table 46. Key Market Drivers & Growth Opportunities of Cancer Tumor Profiling
    Table 47. Key Market Challenges & Risks of Cancer Tumor Profiling
    Table 48. Key Industry Trends of Cancer Tumor Profiling
    Table 49. Global Cancer Tumor Profiling Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 50. Global Cancer Tumor Profiling Market Size Market Share Forecast by Regions (2023-2028)
    Table 51. Global Cancer Tumor Profiling Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 52. Global Cancer Tumor Profiling Market Size Market Share Forecast by Type (2023-2028)
    Table 53. Global Cancer Tumor Profiling Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 54. Global Cancer Tumor Profiling Market Size Market Share Forecast by Application (2023-2028)
    Table 55. Qiagen N.V. Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
    Table 56. Qiagen N.V. Cancer Tumor Profiling Product Offered
    Table 57. Qiagen N.V. Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 58. Qiagen N.V. Main Business
    Table 59. Qiagen N.V. Latest Developments
    Table 60. Roche Molecular Systems Inc. Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
    Table 61. Roche Molecular Systems Inc. Cancer Tumor Profiling Product Offered
    Table 62. Roche Molecular Systems Inc. Main Business
    Table 63. Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 64. Roche Molecular Systems Inc. Latest Developments
    Table 65. Abott Molecular Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
    Table 66. Abott Molecular Cancer Tumor Profiling Product Offered
    Table 67. Abott Molecular Main Business
    Table 68. Abott Molecular Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 69. Abott Molecular Latest Developments
    Table 70. Illumina Inc. Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
    Table 71. Illumina Inc. Cancer Tumor Profiling Product Offered
    Table 72. Illumina Inc. Main Business
    Table 73. Illumina Inc. Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 74. Illumina Inc. Latest Developments
    Table 75. NeoGenomics Laboratories Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
    Table 76. NeoGenomics Laboratories Cancer Tumor Profiling Product Offered
    Table 77. NeoGenomics Laboratories Main Business
    Table 78. NeoGenomics Laboratories Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 79. NeoGenomics Laboratories Latest Developments
    Table 80. HTG Molecular Diagnostic Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
    Table 81. HTG Molecular Diagnostic Cancer Tumor Profiling Product Offered
    Table 82. HTG Molecular Diagnostic Main Business
    Table 83. HTG Molecular Diagnostic Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 84. HTG Molecular Diagnostic Latest Developments
    Table 85. Genomic Health Inc. Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
    Table 86. Genomic Health Inc. Cancer Tumor Profiling Product Offered
    Table 87. Genomic Health Inc. Main Business
    Table 88. Genomic Health Inc. Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 89. Genomic Health Inc. Latest Developments
    Table 90. Hologic Gen-Probe Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
    Table 91. Hologic Gen-Probe Cancer Tumor Profiling Product Offered
    Table 92. Hologic Gen-Probe Main Business
    Table 93. Hologic Gen-Probe Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 94. Hologic Gen-Probe Latest Developments
    Table 95. BD Biosciences Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
    Table 96. BD Biosciences Cancer Tumor Profiling Product Offered
    Table 97. BD Biosciences Main Business
    Table 98. BD Biosciences Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 99. BD Biosciences Latest Developments
    Table 100. Siemens Healthineers Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
    Table 101. Siemens Healthineers Cancer Tumor Profiling Product Offered
    Table 102. Siemens Healthineers Main Business
    Table 103. Siemens Healthineers Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 104. Siemens Healthineers Latest Developments
    Table 105. Claris Life Sciences Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
    Table 106. Claris Life Sciences Cancer Tumor Profiling Product Offered
    Table 107. Claris Life Sciences Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 108. Claris Life Sciences Main Business
    Table 109. Claris Life Sciences Latest Developments
    Table 110. Personal Genome Diagnostics, Inc. Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
    Table 111. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product Offered
    Table 112. Personal Genome Diagnostics, Inc. Main Business
    Table 113. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 114. Personal Genome Diagnostics, Inc. Latest Developments
    Table 115. Perthera, Inc. Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
    Table 116. Perthera, Inc. Cancer Tumor Profiling Product Offered
    Table 117. Perthera, Inc. Main Business
    Table 118. Perthera, Inc. Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 119. Perthera, Inc. Latest Developments
    Table 120. Foundation Medicine, Inc Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
    Table 121. Foundation Medicine, Inc Cancer Tumor Profiling Product Offered
    Table 122. Foundation Medicine, Inc Main Business
    Table 123. Foundation Medicine, Inc Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 124. Foundation Medicine, Inc Latest Developments
    Table 125. V., Strand Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
    Table 126. V., Strand Cancer Tumor Profiling Product Offered
    Table 127. V., Strand Main Business
    Table 128. V., Strand Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 129. V., Strand Latest Developments
    Table 130. ApoCell Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
    Table 131. ApoCell Cancer Tumor Profiling Product Offered
    Table 132. ApoCell Main Business
    Table 133. ApoCell Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 134. ApoCell Latest Developments
    Table 135. Contextual Genomics Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
    Table 136. Contextual Genomics Cancer Tumor Profiling Product Offered
    Table 137. Contextual Genomics Main Business
    Table 138. Contextual Genomics Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 139. Contextual Genomics Latest Developments
    Table 140. Agendia Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
    Table 141. Agendia Cancer Tumor Profiling Product Offered
    Table 142. Agendia Main Business
    Table 143. Agendia Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 144. Agendia Latest Developments
    Table 145. GenScript Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
    Table 146. GenScript Cancer Tumor Profiling Product Offered
    Table 147. GenScript Main Business
    Table 148. GenScript Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 149. GenScript Latest Developments
List of Figures
    Figure 1. Cancer Tumor Profiling Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Cancer Tumor Profiling Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Cancer Tumor Profiling Market Size Market Share by Type in 2021
    Figure 7. Cancer Tumor Profiling in Personalized Medicine
    Figure 8. Global Cancer Tumor Profiling Market: Personalized Medicine (2017-2022) & ($ Millions)
    Figure 9. Cancer Tumor Profiling in Diagnostics
    Figure 10. Global Cancer Tumor Profiling Market: Diagnostics (2017-2022) & ($ Millions)
    Figure 11. Cancer Tumor Profiling in Biomarker Discovery
    Figure 12. Global Cancer Tumor Profiling Market: Biomarker Discovery (2017-2022) & ($ Millions)
    Figure 13. Cancer Tumor Profiling in Prognostics
    Figure 14. Global Cancer Tumor Profiling Market: Prognostics (2017-2022) & ($ Millions)
    Figure 15. Cancer Tumor Profiling in Research Applications
    Figure 16. Global Cancer Tumor Profiling Market: Research Applications (2017-2022) & ($ Millions)
    Figure 17. Global Cancer Tumor Profiling Market Size Market Share by Application in 2021
    Figure 18. Global Cancer Tumor Profiling Revenue Market Share by Player in 2021
    Figure 19. Global Cancer Tumor Profiling Market Size Market Share by Regions (2017-2022)
    Figure 20. Americas Cancer Tumor Profiling Market Size 2017-2022 ($ Millions)
    Figure 21. APAC Cancer Tumor Profiling Market Size 2017-2022 ($ Millions)
    Figure 22. Europe Cancer Tumor Profiling Market Size 2017-2022 ($ Millions)
    Figure 23. Middle East & Africa Cancer Tumor Profiling Market Size 2017-2022 ($ Millions)
    Figure 24. Americas Cancer Tumor Profiling Value Market Share by Country in 2021
    Figure 25. Americas Cancer Tumor Profiling Consumption Market Share by Type in 2021
    Figure 26. Americas Cancer Tumor Profiling Market Size Market Share by Application in 2021
    Figure 27. United States Cancer Tumor Profiling Market Size Growth 2017-2022 ($ Millions)
    Figure 28. Canada Cancer Tumor Profiling Market Size Growth 2017-2022 ($ Millions)
    Figure 29. Mexico Cancer Tumor Profiling Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Brazil Cancer Tumor Profiling Market Size Growth 2017-2022 ($ Millions)
    Figure 31. APAC Cancer Tumor Profiling Market Size Market Share by Region in 2021
    Figure 32. APAC Cancer Tumor Profiling Market Size Market Share by Application in 2021
    Figure 33. China Cancer Tumor Profiling Market Size Growth 2017-2022 ($ Millions)
    Figure 34. Japan Cancer Tumor Profiling Market Size Growth 2017-2022 ($ Millions)
    Figure 35. Korea Cancer Tumor Profiling Market Size Growth 2017-2022 ($ Millions)
    Figure 36. Southeast Asia Cancer Tumor Profiling Market Size Growth 2017-2022 ($ Millions)
    Figure 37. India Cancer Tumor Profiling Market Size Growth 2017-2022 ($ Millions)
    Figure 38. Australia Cancer Tumor Profiling Market Size Growth 2017-2022 ($ Millions)
    Figure 39. Europe Cancer Tumor Profiling Market Size Market Share by Country in 2021
    Figure 40. Europe Cancer Tumor Profiling Market Size Market Share by Type in 2021
    Figure 41. Europe Cancer Tumor Profiling Market Size Market Share by Application in 2021
    Figure 42. Germany Cancer Tumor Profiling Market Size Growth 2017-2022 ($ Millions)
    Figure 43. France Cancer Tumor Profiling Market Size Growth 2017-2022 ($ Millions)
    Figure 44. UK Cancer Tumor Profiling Market Size Growth 2017-2022 ($ Millions)
    Figure 45. Italy Cancer Tumor Profiling Market Size Growth 2017-2022 ($ Millions)
    Figure 46. Russia Cancer Tumor Profiling Market Size Growth 2017-2022 ($ Millions)
    Figure 47. Middle East & Africa Cancer Tumor Profiling Market Size Market Share by Region in 2021
    Figure 48. Middle East & Africa Cancer Tumor Profiling Market Size Market Share by Type in 2021
    Figure 49. Middle East & Africa Cancer Tumor Profiling Market Size Market Share by Application in 2021
    Figure 50. Egypt Cancer Tumor Profiling Market Size Growth 2017-2022 ($ Millions)
    Figure 51. South Africa Cancer Tumor Profiling Market Size Growth 2017-2022 ($ Millions)
    Figure 52. Israel Cancer Tumor Profiling Market Size Growth 2017-2022 ($ Millions)
    Figure 53. Turkey Cancer Tumor Profiling Market Size Growth 2017-2022 ($ Millions)
    Figure 54. GCC Country Cancer Tumor Profiling Market Size Growth 2017-2022 ($ Millions)
    Figure 55. Americas Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 56. APAC Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 57. Europe Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 58. Middle East & Africa Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 59. United States Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 60. Canada Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 61. Mexico Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 62. Brazil Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 63. China Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 64. Japan Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 65. Korea Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 66. Southeast Asia Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 67. India Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 68. Australia Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 69. Germany Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 70. France Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 71. UK Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 72. Italy Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 73. Russia Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 74. Spain Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 75. Egypt Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 76. South Africa Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 77. Israel Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 78. Turkey Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
    Figure 79. GCC Countries Cancer Tumor Profiling Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Cancer Tumor Profiling Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Cancer Tumor Profiling Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Cancer Tumor Profiling Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports